The Effect of Preoperative SGB on POAF After VATS (NCT05753644) | Clinical Trial Compass
UnknownNot Applicable
The Effect of Preoperative SGB on POAF After VATS
China480 participantsStarted 2023-03-27
Plain-language summary
The aim of this study is to test if stellate ganglion block can decrease the incidence of atrial fibrillation after video-assisted thoracoscopic surgery and the way it works.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 1.patients undergoing elective thoracoscopic lobectomy;
* 2.patients with one or more risk factors of POAF. According to literature, risks factors of POAF including male, aged over 65, obesity (BMI\>30kg/m2), cardiac co-morbidity ( hypertension, myocardial infarction, heart failure, arrhythmia, history of valve procedure), diabetes, chronic renal insufficiency (increased creatinine level), obstructive sleep apnea syndrome (diagnosed or STOP-BANG scores ≥3).
Exclusion Criteria:
* 1\. patients with permanent atrial fibrillation, left ventricular or right ventricular pacemaker implantation or removal;
* 2\. patients use antiarrhythmic drugs (except beta-blockers);
* 3.patients use immunosuppressive drugs preoperatively;
* 4.patients with active infection or sepsis;
* 5\. patients with neurologic disorder;
* 6.patients with immune deficiency syndrome.
What they're measuring
1
Primary outcome is the incidence of POAF using dynamic electrocardiogram.